Daiichi Life Insurance Co. Ltd. bought a new position in shares of Rocket Lab Corporation (NASDAQ:RKLB - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 21,859 shares of the rocket manufacturer's stock, valued at approximately $2,222,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Mcguire Capital Advisors Inc. bought a new position in shares of Rocket Lab in the fourth quarter worth $27,000. Zions Bancorporation National Association UT purchased a new stake in shares of Rocket Lab in the fourth quarter worth $28,000. EverSource Wealth Advisors LLC boosted its stake in Rocket Lab by 109.5% during the second quarter. EverSource Wealth Advisors LLC now owns 796 shares of the rocket manufacturer's stock valued at $28,000 after buying an additional 416 shares during the period. Gordian Capital Singapore Pte Ltd bought a new stake in Rocket Lab during the fourth quarter valued at $29,000. Finally, Reflection Asset Management purchased a new position in Rocket Lab during the fourth quarter worth about $30,000. 71.78% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on the company. Roth Capital set a $110.00 target price on Rocket Lab in a research note on Tuesday, August 11th. New Street Research initiated coverage on Rocket Lab in a research report on Wednesday, May 13th. They set a "buy" rating and a $150.00 price target for the company. Needham & Company LLC reissued a "buy" rating on shares of Rocket Lab in a report on Tuesday, August 11th. BTIG Research reaffirmed a "hold" rating on shares of Rocket Lab in a research note on Tuesday, May 12th. Finally, Craig Hallum lifted their target price on shares of Rocket Lab from $98.00 to $120.00 and gave the company a "buy" rating in a research report on Monday, June 29th. Three investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $110.65.
View Our Latest Analysis on Rocket Lab
Trending Headlines about Rocket Lab
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Rocket Lab successfully completed its 93rd Electron mission, deploying an Earth-imaging satellite for Japan’s iQPS. The launch was the company’s 14th of 2026 and extended a 100% success streak for iQPS missions. Nine additional dedicated iQPS launches are booked through 2030, supporting future revenue visibility. Rocket Lab launches 93rd Electron mission
- Positive Sentiment: Recent U.S. Space Force and defense awards are strengthening Rocket Lab’s position as a national-security contractor. Highlights include participation in the NITE-STAR program, with a potential ceiling of $981 million, a protected military communications satellite-bus role, the $397 million Flatellite contract, and a record $266 million missile-defense launch award. The company’s backlog reportedly exceeds $2.3 billion.
- Positive Sentiment: CEO Peter Beck said the proposed $8 billion Iridium acquisition is intended to expand Rocket Lab’s satellite-communications capabilities without directly competing with SpaceX’s Starlink. Management is positioning the deal as a differentiated communications offering, although investors will weigh its strategic benefits against transaction and execution risks. Rocket Lab CEO discusses Iridium deal
- Neutral Sentiment: Analysts remain broadly optimistic, with a reported median price target of $120 and a separate consensus average of $110.65. However, these targets depend heavily on continued contract growth and successful Neutron development.
- Negative Sentiment: Rocket Lab remains unprofitable and recently missed quarterly EPS expectations despite beating revenue estimates. Heavy spending on Neutron has pressured margins, while a first-stage tank issue has pushed Neutron’s debut to the fourth quarter, delaying a major potential growth catalyst.
- Negative Sentiment: Valuation remains demanding after the sell-off, with the company trading at a very high sales multiple and carrying a negative earnings profile. In addition, reports show extensive insider selling—including sales by CEO Peter Beck—without reported insider purchases, which may weigh on sentiment.
- Negative Sentiment: Higher oil prices and rising long-term interest rates have raised concerns about an economic slowdown and weaker industrial orders across aerospace-related stocks. The post-IPO volatility in SpaceX has also continued to pressure the broader space sector.
Rocket Lab Stock Performance
NASDAQ RKLB opened at $72.57 on Monday. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The stock's 50-day simple moving average is $81.86 and its two-hundred day simple moving average is $85.29. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The company has a market capitalization of $43.42 billion, a price-to-earnings ratio of -268.77 and a beta of 2.60.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last posted its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). The firm had revenue of $234.07 million during the quarter, compared to analysts' expectations of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. Research analysts forecast that Rocket Lab Corporation will post -0.2 EPS for the current fiscal year.
Insider Buying and Selling at Rocket Lab
In other Rocket Lab news, CEO Peter Beck sold 1,298,622 shares of Rocket Lab stock in a transaction that occurred on Tuesday, July 7th. The shares were sold at an average price of $84.92, for a total transaction of $110,278,980.24. Following the transaction, the chief executive officer directly owned 2,715,181 shares of the company's stock, valued at approximately $230,573,170.52. This trade represents a 32.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 88,000 shares of the business's stock in a transaction that occurred on Thursday, June 18th. The stock was sold at an average price of $107.98, for a total transaction of $9,502,240.00. Following the completion of the sale, the senior vice president owned 264,705 shares of the company's stock, valued at approximately $28,582,845.90. The trade was a 24.95% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 3,749,294 shares of company stock valued at $351,008,208. 8.40% of the stock is currently owned by corporate insiders.
About Rocket Lab
(
Free Report)
Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.
See Also
Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.